Because pathway compensation is common, combinations that pair macrophage re-education with neutrophil-axis interruption, or that couple stromal TGF-β modulation with myeloid-targeted agents, are likely to be required in immune-excluded CRC. This evidence concerns the gene TGFB1 and colorectal carcinoma.